The Occurrence of Warfarin-Related Nephropathy and Effects on Renal and Patient Outcomes in Korean Patients

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  An, Jung Nam ^a   Ahn, Shin Young ^b   Yoon, Chang Hwan ^b   Youn, Tae Jin ^b   Han, Moon Ku ^b   Kim, Sejoong ^b   Chin, Ho Jun ^b   Na, Ki Young ^b   Chae, Dong Wan ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; WARFARIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; WARFARIN RELATED NEPHROPATHY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CREATININE; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SURVIVAL ANALYSIS; WARFARIN;

EID: 84875639655     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057661     Document Type: Article

References (20)

1. Limdi NA, Limdi MA, Cavallari L, Anderson AM, Crowley MR, et al. (2010) Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis 56: 823-831.
2. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, et al. (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867.
3. Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, et al. (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80: 181-189.
4. Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW,et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54: 1121-1126.
5. Kabir A, Nadasdy T, Nadasdy G, Hebert LA, (2004) An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy. Am J Kidney Dis 43: 757-760.
6. Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, et al. (2010) Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115: c142-146.
7. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, et al. (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 160S-198S.
8. Budnitz DS, Shehab N, Kegler SR, Richards CL, (2007) Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 147: 755-765.
9. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, et al. (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31.
10. Brodsky SV, Rovin BH, Hebert LA, (2012) Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide. Nephrol Dial Transplant 27: 475-477.
11. Tarnoky AL, (1982) Warfarin and albumin. Br Med J (Clin Res Ed) 285: 812.
12. Tsao SC, Sugiyama Y, Sawada Y, Nagase S, Iga T, et al. (1986) Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method. J Pharmacokinet Biopharm 14: 51-64.
13. Wilting J, van der Giesen WF, Janssen LH, Weideman MM, Otagiri M, et al. (1980) The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis. J Biol Chem 255: 3032-3037.
14. Demirkan K, Stephens MA, Newman KP, Self TH, (2000) Response to warfarin and other oral anticoagulants: effects of disease states. South Med J 93: 448-454.
15. Jaffer A, Bragg L, (2003) Practical tips for warfarin dosing and monitoring. Cleve Clin J Med 70: 361-371.
16. Macedo E, Bouchard J, Mehta RL, (2008) Renal recovery following acute kidney injury. Curr Opin Crit Care 14: 660-665.
17. Wald R, Quinn RR, Luo J, Li P, Scales DC, et al. (2009) Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302: 1179-1185.
18. Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordonez JD, et al. (2009) Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 4: 891-898.
19. Lafrance JP, Miller DR, (2010) Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 21: 345-352.
20. Brown JR, Kramer RS, Coca SG, Parikh CR, (2010) Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 90: 1142-1148.